Publications
5538 Results
- Journal / Conference
- Classic Papers and Current Comments 3(1):145-157
- Year
- 1998
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8412
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer
- Journal / Conference
- Journal of Clinical Oncology 16(9):2906-2912
- Year
- 1998
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8593 (INT-0065)
Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: Results of a multicenter randomized phase III trial.
- Journal / Conference
- Cancer Journal from Scientific American 4(Suppl.2):S5-S12
- Year
- 1998
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14
New REAL clinical entities.
- Journal / Conference
- The American Surgeon 64(7):680-685
- Year
- 1998
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Inadequate documentation and resection for gastric cancer in the United States: A preliminary report.
- Journal / Conference
- Statistics in Medicine 17:1469-1479
- Year
- 1998
- Research Committee(s)
- Multiple sites
Design and analysis for survival data under order restrictions with a modified logrank test.
- Journal / Conference
- Blood 92(10)(Suppl.1):314a-315a(#1291)
- Year
- 1998
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-9239
EBV DNA quantitation in serum is highly correlated with the development and regression of post-transplant lymphoproliferative disorder (PTLD) in solid organ tranplant recipients.
- Journal / Conference
- Journal of Clinical Oncology 16(7):2382-2391
- Year
- 1998
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8931 (INT-0108) (EST-3189)
Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: An intergroup study.
- Journal / Conference
- Blood 92(10)(Suppl.1):312a(#1281)
- Year
- 1998
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9126
Benefit of cycloporine (CsA) modulation of anthracycline resistance in high-risk AML: A Southwest Oncology Group (SWOG) study.
- Journal / Conference
- Blood 92(10(Suppl.1):318a(#1305)
- Year
- 1998
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9210
Alternate day oral prednisone maintenance therapy improves progression-free and overall survival in multiple myeloma patients.
- Journal / Conference
- Blood 92(10)(Suppl.1):678a(#2795)
- Year
- 1998
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9034 (EST-3489) (CALGB-9120)